BURGER, J. A. Et Al. 2015. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. NEW ENGLAND JOURNAL OF MEDICINE , vol.373, no.25 , 2425-2437.

BURGER, J. A., TEDESCHI, A., Barr, P. M., ROBAK, T., Owen, C., GHIA, P., ... Bairey, O.(2015). Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. NEW ENGLAND JOURNAL OF MEDICINE , vol.373, no.25, 2425-2437.

BURGER, J. Et Al. "Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia," NEW ENGLAND JOURNAL OF MEDICINE , vol.373, no.25, 2425-2437, 2015

BURGER, J. A. Et Al. "Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia." NEW ENGLAND JOURNAL OF MEDICINE , vol.373, no.25, pp.2425-2437, 2015

BURGER, J. A. Et Al. (2015) . "Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia." NEW ENGLAND JOURNAL OF MEDICINE , vol.373, no.25, pp.2425-2437.

@article{article, author={J. A. BURGER Et Al. }, title={Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2015, pages={2425-2437} }